<DOC>
	<DOCNO>NCT00322062</DOCNO>
	<brief_summary>The aim study compare new 2 litre bowel cleanse product versus sodium phosphate solution already market . Efficacy bowel preparation , safety acceptability assess .</brief_summary>
	<brief_title>MOVIPREP® Versus NaP Pivotal Phase III Study</brief_title>
	<detailed_description>Multicentric ( 15 centre ) , prospective , randomised , single-blinded phase III pivotal study patient undergo colonoscopy . Gut cleanse perform use 2 litre NRL994 gut lavage solution 1 litre ( ) extra clear liquid 2 x 45 ml sodium phosphate solution plus 2 litre ( ) extra clear liquid day colonoscopy . Patients require morning colonoscopy fulfil inclusion criterion , randomise . One two tested product deliver pharmacist , blindly gastroenterologist . The assigned product take day coloscopy accord information leaflet . Efficacy two test preparation measure video-tape record colonoscopy final grading i.e . `` overall quality colonoscopy prep '' gastroenterologist expert . A standardised patient questionnaire administer nurse morning colonoscopy ass clinical tolerance acceptability ( satisfaction ) prep . A baseline blood sample withdraw intake preparation one blood sample perform intake morning , coloscopy . After coloscopy , gastroenterologist give result coloscopy , last visit perform .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Polyethylene glycol 3350</mesh_term>
	<criteria>male female , inpatient least 18 year old &lt; 75 year old send endoscopic ward diagnostic therapeutic colonoscopy willing able complete entire procedure comply study instruction female childbearing potential must employ adequate method contraception . age &lt; 18 &gt; 75 year old ileus suspect intestinal occlusion perforation toxic congenital megacolon history colonic resection patient Crohn 's disease ulcerative colitis congestive heart failure NYHA III IV document renal insufficiency history creatinine &gt; 170µmol/l know hypersensitivity polyethylene glycol Na phosphate and/or vitamin C concurrent participation investigational drug study participation within 90 day study entry female pregnant , plan pregnancy . Females childbearing potential use reliable method contraception subject condition situation investigator opinion may put subject significant risk , may confound study result , may interfere significantly</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Colon cleansing</keyword>
</DOC>